去甲斑蝥素对H446 细胞Id1mRNA 表达的影响

目的:观察去甲斑蝥素对小细胞肺癌H446细胞Id1mRNA表达的影响。方法:分别利用MTT法检测细胞生长活性;用划痕实验分析细胞迁移能力;采用Hoechst染色观察细胞凋亡;用实时荧光RT-PCR法测定H446中Id1mRNA的表达。结果:去甲斑蝥素对H446细胞的生长有明显的抑制作用,细胞的生长抑制率和凋亡率明显增加,细胞迁移距离明显缩短。去甲斑蝥素可抑制细胞内Id1mRNA的表达,其相对定量随去甲斑蝥素的浓度增大而减少。结论:在H446细胞中,去甲斑蝥素能抑制Id1mRNA的表达,这可能是去甲斑蝥素抑制细胞生长,迁移和诱导细胞凋亡的重要机制之一。     

野生型P53、P16基因协同对肺腺癌细胞系生长抑制作用的研究

为了探讨野生型P53基因及P16基因在恶性肿瘤基因治疗中的作用,用腺病毒为载体将野生型P53基因转入高、低转移的肺腺癌细胞系Anip973、AGZY83-a和经野生型P16基因质粒转染的高、低转移肺腺癌细胞系Anip973（Anip973P16）、AGZY83-a（AGZY83-aP16）。对各组转染细胞进行生长曲线、MTT生长抑制率、原位末端标记、Western-blotting等技术检测分析。结果发现（1）野生型P53蛋白的过表达对上述肺腺癌细胞系均呈现出较强的生长抑制作用。（2）野生型P53蛋白的过表达对高转移肺癌细胞系Anip973的抑制作用明显高于低转移细胞系AGZY83-a。（3）野生型p53蛋白的过表达对经野生型P16基因转染的高、低转移的肺癌细胞Anip973、AGZY83-a抑制作用明显高于未经P16基因转染的细胞。野生型P53基因可以作为肺腺癌基因治疗的候选基因。肿瘤抑制基因P53、P16的联合转染可能是对肺腺癌进行基因治疗的有效手段。 Abstract：To investigate the suppression effect of tumor suppressor genes in lung adenocarcinoma cell lines,we transferred a pair of lung adenocarcinoma cell lines with different metastasis potential,Anip973(High-metastasis potential cell line) and AGZY83-a (Low-metastasis potential cell line)and this pair of cell lines transfected with P16 gene:AGZY83-a P16 and Anip973 P16 with wild type P53 gene with adenovirus vector.The suppression effects of P53 gene were evaluated by cell growth curve,MTT,western-blotting analysis and TUNEL technique.Overexpression of wild-type P53 gene in AGZY83-a,Anip973,Anip973 P16 and AGZY83-a P16 inhibited the growth of these four kinds of lung cancer cells and induced apoptosis of the cells.The suppression effect of P53 gene in Anip973 and Anip973 P16 was higher than AGZY83-a and AGZY83-a P16 while co-expression of P53 and　P16 in this pair of cell lines inhibited the cells more efficiently comparing with the expression of P53 alone.Wild-type P53 gene might act as a candidate gene in lung adenocarcinoma gene therapy while co-transfection of P53 and P16 genes was a more effective method.     

一个与非小细胞肺癌转移相关的基因――RAB5A基因

采用mRNA差异展示技术（mRNA DD）研究具有相同细胞来源,但转移能力高低不同的人肺腺癌细胞系AGZY83-a（低转移）和Anip973(高转移),分析在两个细胞系中基因差异表达的情况,发现在高转移细胞系中有RAB5A基因的表达。该基因为蛋白质入胞信号的调控者,为RAS超家族成员。为进一步证实其转录表达的调控改变情况,以及RAB5A高表达的临床意义,进一步采用RT-PCR和免疫组织化学的方法检测了50例临床非小细胞肺癌的手术标本,结果表明,RAB5A的表达有随转移发生而增强的趋势,而RAB5A的蛋白表达程度在有转移的病例中明显增强(P<0.05)。 Abstract：　Using mRNA differential display (mRNA DD)techniques, we analyzed the differences of gene expression between two human lung adenocarcinoma cell lines,AGZY83-a and Anip973. Anip973 was isolated from AGZY83-a, but manifested much higher metastatic potential than the parent line. The results showed that there were significant differences on gene expression between the two cell lines and that there was over-expression of RAB5Agene in the Anip973 cell line. The product of RAB5Agene was recognized as signal regulators of endocytotic pathway and protein trafficking at the cell surface, and belong to a member of the RAS superfamily. Furthemore, we compared to the expression of RAB5Agene and RAB5Aprotein in clinical samples of 50 cases non-small lung carcinoma and nearby lymph node by means of RT-PCR and immunohistochemistry method. The results indicated that the high expression of RAB5Ain metastatic tumor and the enhancement level of RAB5Ain metastatic tumor and the enhancement level of expression were corresponded with the increase of metastatic degree. And there were significance of difference on the expression degree of RAB5Aprotein between non-small lung carcinoma with metastasis and non- metastasis (P<0.05).     

一个与非小细胞肺癌转移相关的基因--RAB5A基因

采用mRNA差异展示技术(mRNA DD)研究具有相同细胞来源,但转移能力高低不同的人肺腺癌细胞系AGZY83-a(低转移)和Anip973(高转移),分析在两个细胞系中基因差异表达的情况,发现在高转移细胞系中有RAB5A基因的表达.该基因为蛋白质入胞信号的调控者,为RAS超家族成员.为进一步证实其转录表达的调控改变情况,以及RAB5A高表达的临床意义,进一步采用RT-PCR和免疫组织化学的方法检测了50例临床非小细胞肺癌的手术标本,结果表明,RAB5A的表达有随转移发生而增强的趋势,而RAB5A的蛋白表达程度在有转移的病例中明显增强(P<0.05).     

人肺癌细胞抑癌基因PTEN的表达与失巢凋亡的关系

应用Northern印迹、Western印迹和DNA梯形片段方法 ,研究 8株不同细胞类型的人肺癌细胞中抑癌基因PTEN的表达与失巢凋亡 (anoikis)的关系 ,并分析在此过程中蛋白激酶B(proteinkinaseB ,PKB)和粘着斑激酶(focaladhesionkinase ,FAK)的作用。发现 8株人肺癌细胞PTEN均有mRNA表达 ,且mRNA水平比较接近。但PTEN的蛋白质水平不一致 ,其中 95C、95D和A1株的PTEN蛋白未检测到 ;A549、A4、A7和L1株的PTEN蛋白有表达 ,但较低 ;而H460 株的PTEN表达较强。PTEN缺失的 95D和高表达的H460 细胞株中PTENcDNA序列分析均未发生片断缺失或点突变。RNA稳定性分析表明 ,95DmRNA稳定性较H460 明显下降。在无血清且去粘附培养条件下 ,高表达PTEN的细胞株H460 可被诱导发生失巢凋亡现象 ,在 10 %血清培养条件下可保护其免于失巢凋亡 ,而PTEN缺失的 95D等和其他PTEN低表达的细胞株却没有发生诱导失巢凋亡现象。进一步研究发现PTEN表达可降低PKB的磷酸化 ,下调FAK蛋白质的表达。结果提示各种人肺癌细胞株中PTEN蛋白表达存在显著差异。PTEN参与了失巢凋亡的发生。     

酶解条浒苔蛋白制备抗肺癌活性多肽

为了开发利用绿潮藻类条浒苔中含量丰富的蛋白质,采用木瓜蛋白酶酶解条浒苔蛋白,最佳酶解条件为:料液比1∶25、加酶量1 250 U/g pro、温度45.7℃、pH 7.2、震荡酶解时间120 min。在该条件下的酶解多肽经超滤分离获得不同分子量区间的多肽,并通过HUVEC、A549、H446、H460等细胞水平初步评价酶解条浒苔制备多肽抗肺癌的细胞生物学效果。结果表明,经上述条件获得的2-6 kD条浒苔多肽处理的HUVEC在抗氧化和小管形成等方面均受到抑制,其处理的NCI-H460、NCI-H446和A549的增殖、细胞周期、迁移也受到不同程度抑制,且能够促进细胞凋亡;2-6 kD浒苔多肽对H446、H460作用效果显著优于对A549的作用。这一细胞水平研究,不仅证实了酶解条浒苔获取新型天然抗肿瘤小肽的可行性,也为条浒苔蛋白质资源高值化利用探索提供了新的途径。     

DADS对人小细胞肺癌NCI-H446细胞系增殖抑制的研究

目的：研究二烯丙基二硫（diallyldisulfide,DADS）对人小细胞肺癌NCI．H446细胞增殖的抑制作用,并探讨其作用机制。方法：体外培养NCI-H446细胞,采用MTT、细胞计数实验方法检测DADS抑制NCI—H446细胞增殖;通过HE染色和AO—EB荧光染色方法,观察DADS处理后NCI—H446细胞的形态学改变。结果：MTT结果显示：DADS作用于NCI—H446细胞48h后,代谢MTT的能力明显降低,显示出较强的细胞毒性反应,IC50值介于20-40μg／ml之间。细胞计数结果表明：DADS作用于NCI—H446细胞后,随DADS浓度增加NCI—H446细胞倍增时间延长。HE染色显示：NCI—H446细胞经DADS处理24h后,与对照组相比,细胞体积变小,胞浆丰富,细胞核变小,染色变淡。AO-EB荧光染色显示：NCI-H446细胞经DADS处理24h后,与对照组相比,细胞皱缩、呈圆形,胞质黄色或橘红色,细胞核或细胞质内可见致密浓染的黄绿色或橘红色荧光,并可见橘红色碎片且随DADS浓度增加,随DADS浓度增加细胞密度逐渐减少。结论：DADS能抑制体外培养的NCI—H446细胞增殖,作用效果与药物浓度及作用时间相关。     

RAB5A蛋白G81R位点突变对其功能的影响

为探讨G81R位点突变对RAB5A蛋白功能的影响,将RAB5A G81R突变体和正常RAB5A反义RNA分别插入pcDNA3．1／V5-His TOPO真核表达载体,并转染到Anip973细胞。用Western blot方法检测稳定转染后细胞RAB5A蛋白的表达水平,通过血清饥饿法使Anip973和转染后的细胞同步化,停滞于G0～G1期,再恢复血清培养使细胞从G0～G1期释放,用流式细胞分析仪分析细胞周期各时相细胞百分比。结果显示RAB5A G81R突变体的反义RNA可完全封闭Anip973细胞中RAB5A的表达,正常RAB5A反义RNA部分封闭RAB5A表达。并且,Anip973细胞周期的长短与RAB5A的表达程度成反比。RAB5A G81R反义RNA能够有效地阻断Anip973细胞中RAB5A蛋白的表达。阻断或降低RAB5A的表达可延长细胞周期。     

一个在肺腺癌细胞系中差异表达cDNA片段的定位及表达分析

为了研究和克隆肺癌转移相关候选基因,探讨肺癌发生及转移的分子基础,应用细胞培养,cDNA克隆,Noorthern印记杂交和生物信息学技术分析了在细胞来源相同,但转移能力不同的肺腺癌细胞系AGZY83－a和Anip973中差异表达片段OPB7－1在人不同组织中和不同人肺癌细胞系中的表达情况,并应用RH定位技术对该片段进行了基因定位。表明OPB7－1与已知基因同源性差,该基因在正常人多种组织中有表达,心肌和骨骼肌中高表达,转录本均为3.0kb左右。在不同人肺癌细胞系中存在该基因的表达差异,高转移潜能,低分化及高浸润的细胞系中呈高表达趋势,且表达的片段大小略有差别。提示OPB7－1是一个具有广泛表达为的基因,可能是与肺癌的发生发展相关的新基因。     

RhoGDI2在肺鳞癌、腺癌组织和肺癌细胞系中的表达及其临床意义

目的本研究探讨RhoGDI2在肺鳞癌和腺癌组织及肺癌细胞系中的作用及其临床意义。方法采用免疫组织化学和RT-PCR方法检测112例肺癌组织标本中RhoGDI2蛋白和20例新鲜肺癌组织中RhoGDI2 mRNA的表达,结合肺癌的临床病理特点进行分析。同时应用Western blot和RT-PCR方法检测肺癌细胞系中RhoGDI2蛋白和mRNA水平的表达情况。结果肺鳞癌和腺癌组织中RhoGDI2的表达与组织分级有关,随着分化程度的降低,RhoGDI2蛋白表达降低(P0.01);与TNM分期有关,随着分期级别的升高,RhoGDI2蛋白表达降低(P0.01);与是否淋巴结转移有关,存在淋巴结转移的标本,RhoGDI2蛋白表达降低(P0.01)。RhoGDI2蛋白的表达与组织类型、患者的年龄和性别无关。在选取的肺癌细胞系A549、95D、SPC-A-1和NCI-H446中,无论mRNA水平还是蛋白水平RhoGDI2都有表达,但表达水平不尽相同,在A549、NCI-H446细胞系中表达较低,在SPC-A-1、95D细胞系中表达相对较高。结论RhoGDI2与肺癌的发生发展和转移过程有关,进一步研究RhoGDI2与其作用因子之间的相互作用,将有助于进一步揭示肺癌发生发展及转移过程。     

Upregulation of BNIP3 promotes apoptosis of lung cancer cells that were induced by p53

It has been shown that p53 induces cell apoptosis and the Bcl-2 family plays key roles in this process. However, the molecular mechanism of p53 apoptotic pathway is still unclear. Here, we show that overexpression of exogenous wild-type p53 induced apoptosis in lung cancer cells and high metastasis potential cells had a faster rate of apoptosis than low metastasis potential cells. The expression of pro-apoptotic gene BNIP3 was increased significantly both in Anip973 and 95D cell lines which have high metastasis ability, but not AGZY83-a or little increased in 95C cell lines which possess low metastasis ability. Overexpression of BNIP3 increases apoptotic rate induced by p53 in AGZY83-a cells. Blocking the expression of BNIP3 by siRNA in Anip973 cells decreased apoptotic rate mediated by p53. Taken together, these data suggest that high level expression of BNIP3 mediated rapid apoptosis that was triggered by p53 in lung cancer cells.     

DJ-1 may contribute to metastasis of non-small cell lung cancer

Lung cancer is a leading cause of cancer-related death, about 40% human non-small cell lung cancer (NSCLC) patients showed lymph node involvements. However, the precise mechanism for the metastasis is still not fully understood. This study was to analyze the potential molecular mechanism for lung cancer metastasis. In the current study, proteomics analysis by two-dimensional electrophoresis (2-DE) was performed first to identify the differentially expressed protein between the higher metastasis lung adenocarcinoma cell line Anip973 and the lower metastasis lung adenocarcinoma cell line AGZY83-a. We confirmed the result by RT-PCR, immunoblotting and immunocytochemistry analyses in these two cell lines. Then we examined the expression of the differentially expressed protein in tumor tissues of NSCLC patients by immunoblotting and immunohistochemistry analyses. Using 2-DE analysis, we have identified DJ-1 was expressed higher in the higher metastasis Anip973 compared to the parental cell line AGZY83-a, that was confirmed by RT-PCR, immunoblotting and immunocytochemistry analyses. In NSCLC patients?? tumor tissues study, immunoblotting data showed that, DJ-1 expression level was significantly higher in 72.2% (13/18) of NSCLC tissue samples compared to that in paired normal lung tissues (P?=?0.044). Immunohistochemistry analysis demonstrated increased DJ-1 expression in 85 NSCLC tumor tissue samples compared with 7 normal lung tissue samples (P?=?0.044). DJ-1 expression was also found to be significantly correlated with cancer lymphatic metastasis (P?=?0.039). DJ-1 might contribute to the metastasis of NSCLC.     

Cyclin D1 regulates lung cancer invasion and metastasis

Cyclin D1, as a regulatory factor in cell cycle, is highly expressed in many tumors, such as lung cancer, breast cancer and thyroid cancer. The aim of the present study was to study the role of Cyclin D1 in invasion and metastasis of lung cancer cells. Lung adenocarcinoma cell line A549 and squamous cell line SK-MES-1 were selected as the objects, because A549 expresses Cyclin D1 highly, and SK-MES-1 expresses lowly. Nude mice were injected with A549 or SK-MES-1 via tail vein, and were sacrificed after 4 weeks for cancer tissue isolation. The harvested cancer cells were reinjected into another nude mouse. After one more time of such seeding, highly metastatic lung cancer model was established. After A549 and SK-MES-1 were transfected with Cyclin D1 RNAi and expression vector respectively, transwell migration assay was used to analyze transferring capacity of lung cancer cells. Western blot was used to detect Cyclin D1 and WNT/TCF pathway proteins expressions in parental cell lines and cancer tissue from metastasis model animals. The results showed that, along with the increase of seeding times, lung cancer cells from model animals, no matter A549 or SK-MES-1, exhibited augmented metastasis activity and up-regulated Cyclin D1 expression. The transferring capacity was weakened significantly in A549 cells where the Cyclin D1 was interfered by RNAi, and it was enhanced significantly in SK-MES-1 cells which were transfected with the expression vector of Cyclin D1. The expressions of WNT/TCF pathway proteins, including β-catenin, lymphoid enhancer-binding factor (LEF) and T cell factor (TCF), increased significantly in highly metastatic model animals. The parental cell lines showed lower expressions of WNT/TCF pathway proteins compared with cancer tissue from metastasis model animals. These results suggest that Cyclin D1 is closely related with the invasion and metastasis of lung cancer cells, and the WNT/TCF signal pathway may promote the expression of Cyclin D1.     

水飞蓟宾诱导肺腺癌Anip973细胞凋亡的分子机制研究

目的：探讨水飞蓟宾诱导肺腺癌Anip973细胞系细胞凋亡的分子机制。方法：采用MTT法、倒置显微镜和电子显微镜等形态学检测以及流式细胞仪（FCM）技术检测、DNALadder分析、凋亡分子PARP的表达检测细胞凋亡,同时进行凋亡相关蛋白Bax、Bcl-2、caspase-3和caspase-9表达活性分析。结果：（1）水飞蓟宾对人肺腺癌Anip973细胞系细胞的增殖有显著抑制作用;（2）水飞蓟宾作用Anip973细胞48h后,随着浓度的增加,倒置显微镜下可见细胞数目减少,胞体变小、变圆,到高浓度时出现较多的死亡细胞;（3）扫描电镜观察发现,随着水飞蓟宾作用浓度的增加,Anip973细胞中出现增多的凋亡细胞,凋亡细胞表现出典型的超微结构特征;（4）流式细胞仪检测的结果发现,随着药物作用时间的延长,Anip973细胞的G1期细胞比例增多,S期细胞明显减少,G2期细胞略有减少,并出现明显的凋亡峰。（5）水飞蓟宾作用后的Anip973细胞出现明显的DNALadder和PARP降解增加等凋亡特征;（6）水飞蓟宾作用后,Anip973细胞中的凋亡相关蛋白Bax表达增加、caspase-3和caspase-9酶活性增加,而Bcl-2表达降低。结论：水飞蓟宾在体外有抑制人肺腺癌细胞Anip973的增殖作用,并通过激活线粒体依赖的caspase凋亡通路,诱导其凋亡。     

水飞蓟宾诱导肺腺癌Anip973 细胞凋亡的分子机制研究

目的:探讨水飞蓟宾诱导肺腺癌Anip973细胞系细胞凋亡的分子机制。方法:采用MTT法、倒置显微镜和电子显微镜等形态学检测以及流式细胞仪(FCM)技术检测、DNALadder分析、凋亡分子PARP的表达检测细胞凋亡,同时进行凋亡相关蛋白Bax、Bcl-2、caspase-3和caspase-9表达活性分析。结果:(1)水飞蓟宾对人肺腺癌Anip973细胞系细胞的增殖有显著抑制作用;(2)水飞蓟宾作用Anip973细胞48h后,随着浓度的增加,倒置显微镜下可见细胞数目减少,胞体变小、变圆,到高浓度时出现较多的死亡细胞;(3)扫描电镜观察发现,随着水飞蓟宾作用浓度的增加,Anip973细胞中出现增多的凋亡细胞,凋亡细胞表现出典型的超微结构特征;(4)流式细胞仪检测的结果发现,随着药物作用时间的延长,Anip973细胞的G1期细胞比例增多,S期细胞明显减少,G2期细胞略有减少,并出现明显的凋亡峰。(5)水飞蓟宾作用后的Anip973细胞出现明显的DNALadder和PARP降解增加等凋亡特征;(6)水飞蓟宾作用后,Anip973细胞中的凋亡相关蛋白Bax表达增加、caspase-3和caspase-9酶活性增加,而Bcl-2表达降低。结论:水飞蓟宾在体外有抑制人肺腺癌细胞Anip973的增殖作用,并通过激活线粒体依赖的caspase凋亡通路,诱导其凋亡。     

13q14断裂重排与非小细胞肺癌转移潜能关系的研究

肿瘤转移的细胞经常存在染色体数目异常和结构畸变,在多种有转移潜能的肿瘤细胞中都涉及到13q14的异常。以往研究表明在同一组织来源但转移潜能不同的肺腺癌细胞系AGZY83-a和Anip973中存在13q14的断裂重排。采用mRNA差异展示技术（mRNA DD）分析这一对细胞系得到的差异表达基因BRI基因位于13q14。为了进一步分析肺癌细胞的转移潜能与13q14断裂重排间的关系,采用13q涂染探针对具有不同转移潜能的非小细胞肺癌细胞系PAa、SPC-1-A和95D中期分裂相进行G显带后的荧光原位杂交分析。结果发现在3个肺癌细胞系中有多种13号染色体长臂的结构异常,其中此3个细胞系均涉及13q32-33的频发断裂。但是低转移肺癌细胞系PAa、SPC-1-A均未涉及13q14的断裂,而高转移肺癌细胞系95D的两种细胞克隆均可见13q14的断裂。提示13q14断裂点与肺癌细胞的转移能力有一定的相关性,两者之间的遗传学意义需要进一步研究探索。     

Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft

Polyphyllin I (PPI), a small molecular monomer extracted from Rhizoma of Paris polyphyllin, shows strong anticancer effects in previous study. Human lung adenocarcinoma A549 cells, human lung squamous cell carcinoma SK-MES-1 cells, and human lung large cell carcinoma H460 cells were cultured and then treated with PPI. Cell proliferation and apoptosis were measured by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay, flow cytometry, western blot analysis, and DNA ladder. Athymic nude mice bearing tumors were injected with PPI, and tumor growth was recorded. Our results showed that PPI significantly inhibited the proliferation of three non-small cell lung cancer (NSCLC) cell lines, with the inhibitory concentrations (IC50) of 1.24, 2.40, and 2.33 μg/ml for A549, H460, and SK-MES-1 cells, respectively. After being treated with 2.5 μg/ml of PPI for 24 h, the apoptotic rate of A549 cells was 39.68%, which was remarkably higher than that of the control. Tumor growth was significantly inhibited in the PPI-treated group compared with the group treated with cisplatin (DDP) or PBS in the nude mice. PPI exhibits antitumor ability in NSCLC cells in vitro and in vivo, which might be related to the apoptosis induced by PPI.